Citadel Advisors
GEVA

Citadel Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Citadel Advisors’s Portfolio GEVA Stock Details GEVA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Hold
2015
Q1 		– Sell
2014
Q4 		$1.11M Buy
2014
Q3 		$801K Sell
2014
Q2 		$1.69M Sell
2014
Q1 		$2.58M Buy
2013
Q4 		$327K Buy